For the quarter ending 2026-03-31, BIAF has $7,945,252 in assets. $4,283,866 in debts. $3,098,366 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 3,098,366 | 6,449,782 | 7,669,195 | 802,835 |
| Accounts and other receivables, net | 685,235 | 541,962 | 448,990 | 421,869 |
| Inventory | 77,887 | 53,548 | 35,234 | 43,971 |
| Prepaid expenses and other current assets | 479,913 | 519,916 | 460,187 | 400,151 |
| Total current assets | 4,341,401 | 7,565,208 | 8,613,606 | 1,668,826 |
| Property and equipment, gross | 952,831 | 969,839 | 969,839 | - |
| Less accumulated depreciation and amortization | 705,982 | 704,246 | 666,717 | - |
| Property and equipment, net | 246,849 | 265,593 | 303,122 | 351,368 |
| Operating lease right-of-use asset, net | 651,430 | 334,289 | 367,398 | 399,879 |
| Finance lease right-of-use asset, net | 586,048 | 661,575 | 113,553 | 167,730 |
| Goodwill | 1,404,486 | 1,404,486 | 1,404,486 | 1,404,486 |
| Intangible assets, net | 702,222 | 716,806 | 731,389 | 745,972 |
| Other assets | 12,816 | 12,815 | 12,815 | 12,814 |
| Total assets | 7,945,252 | 10,960,772 | 11,546,369 | 4,751,075 |
| Accounts payable | 836,211 | 761,901 | 940,761 | 1,169,837 |
| Accrued expenses | 2,033,924 | 1,717,989 | 984,547 | 1,048,034 |
| Unearned revenue | 31,140 | 42,405 | 37,915 | 24,404 |
| Operating lease liability, current portion | 142,303 | 139,220 | 136,197 | 133,239 |
| Finance lease liability, current portion | 80,241 | 139,490 | 123,757 | 179,844 |
| Notes payable, current portion | 61,141 | 105,161 | 136,396 | 32,946 |
| Total current liabilities | 3,184,960 | 2,906,166 | 2,359,573 | 2,588,304 |
| Operating lease liability, net of current portion | 545,157 | 202,878 | 238,942 | 274,074 |
| Finance lease liability, net of current portion | 514,834 | 532,759 | 1,998 | 3,942 |
| Warrant liability | - | - | - | 3,974,911 |
| Notes payable, net of current portion | 38,915 | 41,313 | 43,658 | 45,952 |
| Total liabilities | 4,283,866 | 3,683,116 | 2,644,171 | 6,887,183 |
| Preferred stock, par value 0.001 per share 20,000,000 shares authorized 700 shares issued and outstanding at march 31, 2026, and december 31, 2025, respectively | 1 | 1 | 1 | - |
| Common stock, par value 0.007 per share 350,000,000 shares authorized 4,498,675 shares issued and outstanding as of march 31, 2026, and december 31, 2025 | 31,464 | 31,461 | 24,264 | 197,236 |
| Additional paid-in capital | 75,814,595 | 75,800,258 | 74,294,531 | 58,032,170 |
| Accumulated deficit | -72,184,674 | -68,554,064 | -65,416,598 | -60,365,514 |
| Total stockholders equity | 3,661,386 | 7,277,656 | 8,902,198 | -2,136,108 |
| Total liabilities, and stockholders equity | 7,945,252 | 10,960,772 | 11,546,369 | 4,751,075 |
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies, Inc. (BIAF)